Hybrid Systems of Gels and Nanoparticles for Cancer Therapy: Advances in Multifunctional Therapeutic Platforms

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Cancer remains a significant global health challenge requiring innovative therapeutic strategies.
• Nanomedicines like silica nanoparticles and MOFs show promise for targeted cancer therapy via the EPR effect.
• Bare nanoparticles exhibit limitations such as poor biocompatibility, stability, drug loading, and rapid clearance by the reticuloendothelial system (RES).

Purpose of the Study:

• To review gel-nanoparticle hybrid systems for cancer treatment developed in the last five years.
• To analyze the crucial roles of gels in overcoming the limitations of bare nanoparticles.
• To highlight the potential of these hybrid systems in advancing cancer nanomedicine.

Main Methods:

• Literature review focusing on gel-nanoparticle hybrid systems for cancer therapy published within the last five years.
• Analysis of the structural and functional contributions of gel components in hybrid systems.
• Evaluation of enhanced properties including biocompatibility, drug loading, controlled release, and tumor targeting.

Main Results:

• Gel hybridization significantly improves nanoparticle biocompatibility and stability.
• Hybrid systems demonstrate enhanced drug-loading capacity and controlled release kinetics.
• Gels impart cancer-targeting capabilities, improving selective accumulation in tumors.
• Gel-nanoparticle hybrids effectively address the limitations associated with bare nanoparticles.

Conclusions:

• Gel-nanoparticle hybrid systems represent a promising advancement in cancer nanomedicine.
• Gels play a vital role in enhancing the therapeutic efficacy and safety of nanocarriers.
• These hybrid systems offer a versatile platform for developing next-generation cancer treatments.